Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nuvectra Corp (NVTR)

Nuvectra Corp (NVTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,325
  • Shares Outstanding, K 17,885
  • Annual Sales, $ 48,830 K
  • Annual Income, $ -48,130 K
  • 60-Month Beta 0.69
  • Price/Sales 0.06
  • Price/Cash Flow N/A
  • Price/Book 0.04
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.97
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/25/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.87
  • Growth Rate Est. (year over year) +114,927.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.13 unch
on 11/21/19
1.88 -93.09%
on 10/22/19
-1.72 (-92.97%)
since 10/21/19
3-Month
0.13 unch
on 11/21/19
2.52 -94.84%
on 08/29/19
-1.32 (-91.03%)
since 08/21/19
52-Week
0.13 unch
on 11/21/19
20.85 -99.38%
on 12/03/18
-17.09 (-99.25%)
since 11/21/18

Most Recent Stories

More News
Integer Updates 2019 Guidance Following Customer Chapter 11 Filing, No change in prior view of 2020 sales outlook

Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced the following related to the Chapter 11 filing of Nuvectra Corporation ("Nuvectra"), a customer...

NVTR : 0.13 (-23.17%)
ITGR : 78.85 (-1.15%)
Nuvectra(R) Continuing to Support Current Patients with the Algovita(R) Implant as Company Voluntarily Files for Chapter 11

Nuvectra Corporation (NASDAQ: NVTR) ("Nuvectra" or the "Company"), a neurostimulation medical device company, today announced that it has elected to file a voluntary petition for reorganization under Chapter...

NVTR : 0.13 (-23.17%)
Will Nuvectra (NVTR) Report Negative Q3 Earnings? What You Should Know

Nuvectra (NVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NVTR : 0.13 (-23.17%)
Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis(TM)

Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition and biocompatibility data to the U.S. Food and Drug Administration...

NVTR : 0.13 (-23.17%)
Axonics (AXNX) Upbeat on Results of Its ARTISAN-SNM Study

Axonics (AXNX) expects to improve performance on the positive outcome of the study.

ABT : 86.35 (+0.44%)
NVTR : 0.13 (-23.17%)
MDT : 113.52 (+1.01%)
AXNX : 25.51 (-1.20%)
Nuvectra(R) Appoints Jennifer Kosharek as Chief Financial Officer

Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective September 16, 2019. Ms. Kosharek...

NVTR : 0.13 (-23.17%)
Nuvectra(R) Exploring Strategic Options to Enhance Shareholder Value

Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore potential strategic alternatives to enhance shareholder...

NVTR : 0.13 (-23.17%)
Nuvectra (NVTR) Reports Q2 Loss, Lags Revenue Estimates

Nuvectra (NVTR) delivered earnings and revenue surprises of 23.46% and -0.59%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

NVTR : 0.13 (-23.17%)
Nuvectra: 2Q Earnings Snapshot

PLANO, Texas (AP) _ Nuvectra Corp. (NVTR) on Wednesday reported a loss of $11.1 million in its second quarter.

NVTR : 0.13 (-23.17%)
Nuvectra(R) Reports Second Quarter 2019 Financial Results

Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2019.

NVTR : 0.13 (-23.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade NVTR with:

Business Summary

Nuvectra Corporation develops and commercializes neuromodulation medical device for the treatment of nervous system disorders. It also provides neural interface technology, components and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. Nuvectra Corporation is based...

See More

Key Turning Points

2nd Resistance Point 0.21
1st Resistance Point 0.17
Last Price 0.13
1st Support Level 0.11
2nd Support Level 0.09

See More

52-Week High 20.85
Fibonacci 61.8% 12.93
Fibonacci 50% 10.49
Fibonacci 38.2% 8.05
Last Price 0.13
52-Week Low 0.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar